Core Scientific R&D Spending Growth & History (CORZ)
Core Scientific's r&d spending was $11.8M for fiscal 2024.
View full Core Scientific company overviewCore Scientific annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | $11.8M | $4.6M | +64.67% |
| 2023 | 2023-12-31 | $7.2M | −$19.8M | −73.36% |
| 2022 | 2022-12-31 | $27.0M | $19.3M | +251.34% |
| 2021 | 2021-12-31 | $7.7M | $2.4M | +45.59% |
| 2020 | 2020-12-31 | $5.3M | — | — |
Core Scientific quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | $5.0M | $3.1M | +167.38% |
| Q3 2024 | 2024-09-30 | $2.8M | $588,000 | +26.10% |
| Q2 2024 | 2024-06-30 | $2.2M | $534,000 | +32.56% |
| Q1 2024 | 2024-03-31 | $1.8M | $384,000 | +27.14% |
| Q4 2023 | 2023-12-31 | $1.9M | −$781,000 | −29.39% |
| Q3 2023 | 2023-09-30 | $2.3M | −$3.9M | −63.61% |
| Q2 2023 | 2023-06-30 | $1.6M | −$13.1M | −88.90% |
| Q1 2023 | 2023-03-31 | $1.4M | −$1.9M | −57.63% |
| Q4 2022 | 2022-12-31 | $2.7M | −$786,000 | −22.83% |
| Q3 2022 | 2022-09-30 | $6.2M | $4.6M | +290.42% |
| Q2 2022 | 2022-06-30 | $14.8M | $13.3M | +928.04% |
| Q1 2022 | 2022-03-31 | $3.3M | $2.1M | +176.49% |
| Q4 2021 | 2021-12-31 | $3.4M | — | — |
| Q3 2021 | 2021-09-30 | $1.6M | — | — |
| Q2 2021 | 2021-06-30 | $1.4M | — | — |
| Q1 2021 | 2021-03-31 | $1.2M | — | — |
Core Scientific r&d spending trends
Between the periods ended 2020-12-31 and 2024-12-31, Core Scientific's r&d spending increased from $5.3M to $11.8M, a change of $6.6M. The latest reported quarter, Q4 2024, shows $5.0M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Core Scientific source filings ↗